Instil Bio, Inc. TIL
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 3.73% | 0.12% | 29.33% |
| Total Depreciation and Amortization | -- | -- | -85.21% | -67.66% | -45.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 26.77% | 72.34% | -23.16% |
| Change in Net Operating Assets | -- | -- | 95.56% | 50.30% | -1,619.57% |
| Cash from Operations | -- | -- | 34.25% | 31.47% | 5.93% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -50.12% | -64.67% | -64.59% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -52.84% | -43.43% | 1.81% |
| Cash from Investing | -- | -- | -52.80% | -44.18% | 12.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -14,012.10% |
| Issuance of Common Stock | -- | -- | 2,027.12% | 4,912.58% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 65.60% | -- | -- |
| Cash from Financing | -- | -- | 315.50% | 5,489.94% | 1,576.83% |
| Foreign Exchange rate Adjustments | -- | -- | 121.28% | 45.83% | 123.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -6,180.33% | 83.29% | 106.55% |